Features and Parameters of Drug-Eluting Stent Deployment Discoverable by Intravascular Ultrasound
- 1 October 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (8) , S26-S35
- https://doi.org/10.1016/j.amjcard.2007.08.019
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Sirolimus‐Eluting Stent in Chronic Total Occlusion: The SICTO StudyJournal of Interventional Cardiology, 2006
- Impact of Asymmetric Stent Expansion on Neointimal Hyperplasia Following Sirolimus-Eluting Stent ImplantationThe American Journal of Cardiology, 2005
- Impact of Intravascular Ultrasound Lesion Characteristics on Neointimal Hyperplasia Following Sirolimus-Eluting Stent ImplantationThe American Journal of Cardiology, 2005
- Evaluation of Four-Year Coronary Artery Response After Sirolimus-Eluting Stent Implantation Using Serial Quantitative Intravascular Ultrasound and Computer-Assisted Grayscale Value Analysis for Plaque Composition in Event-Free PatientsJournal of the American College of Cardiology, 2005
- Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting StentsCirculation, 2005
- Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients Insights from the RAVEL TrialEuropean Heart Journal, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary ArteriesCirculation, 2003
- Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) TrialCirculation, 2002
- Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting StentsCirculation, 2001